Products
| Product | Information | |
|---|---|---|
| ROLVEDON® (eflapegrastim-xnst) injection, for subcutaneous use | Visit the product website for Important Safety Information, and read the full Prescribing Information. | |
MedWatch
To report SUSPECTED ADVERSE REACTIONS, contact Assertio Holdings, Inc. at 866-458-6389 or FDA at 1-800-FDA-1088 or www.fda.gov/safety/medwatch.
MEDICAL INFORMATION
To answer patient or healthcare provider questions regarding Assertio products including Customer Service, Product Information or Adverse Event Reporting, contact us at 800-518-1084 or medinfo@assertiotx.